Headlands Technologies’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301K Buy
+1,973
New +$302K 0.03% 496
2024
Q2
Sell
-6,687
Closed -$647K 1470
2024
Q1
$647K Buy
+6,687
New +$686K 0.16% 157
2023
Q1
Sell
-7,901
Closed -$717K 687
2022
Q4
$717K Buy
+7,901
New +$665K 0.57% 44

Other funds holding NVS

Headlands Technologies's NVS Position: Q1 2026 in Review

Headlands Technologies opened a new position in Novartis (NVS) in Q1 2026: 1,973 shares worth $301K. The stake represents 0.03% of the portfolio and ranks #496 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in NVS as recently as Q1 2024.

Headlands Technologies first reported a position in NVS in Q4 2022 and has held it in 3 quarters since. The position peaked at $717K in Q4 2022. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Headlands Technologies held 1,973 shares of Novartis worth $301K as of Q1 2026.
  • Novartis was a new Headlands Technologies position in Q1 2026.
  • Novartis made up 0.03% of Headlands Technologies's portfolio in Q1 2026, its #496 holding.
  • Headlands Technologies first reported a position in Novartis in Q4 2022 and has held it in 3 quarters since.
  • Headlands Technologies's Novartis position peaked at $717K in Q4 2022.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.